Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro.

Lass-Flörl C, Dierich MP, Fuchs D, Semenitz E, Jenewein I, Ledochowski M.

J Antimicrob Chemother. 2001 Dec;48(6):775-9.

PMID:
11733460
2.

Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro.

Heller I, Leitner S, Dierich MP, Lass-Flörl C.

Int J Antimicrob Agents. 2004 Oct;24(4):401-4.

PMID:
15380269
4.

Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method.

Lass-Flörl C, Speth C, Kofler G, Dierch MP, Gunsilius E, Würzner R.

Int J Antimicrob Agents. 2003 Mar;21(3):229-33.

PMID:
12636983
5.

MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.

Schmitt HJ, Bernard EM, Andrade J, Edwards F, Schmitt B, Armstrong D.

Antimicrob Agents Chemother. 1988 May;32(5):780-1.

6.

Antifungal activity of a new triazole, voriconazole (UK-109496), against clinical isolates of Aspergillus spp.

Maesaki S, Iwakawa J, Higashiyama Y, Miyazaki Y, Yanagihara K, Tomono K, Tashiro T, Kohno S.

J Infect Chemother. 2000 Jun;6(2):101-3.

PMID:
11810544
7.
8.

[The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].

Xu Y, Pang GR, Lü XF, Chen ZJ, Sun ST, Song JZ.

Zhonghua Yan Ke Za Zhi. 2006 Apr;42(4):309-12. Chinese.

PMID:
16762206
9.

Antifungal properties of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro.

Lass-Flörl C, Wiedauer B, Mayr A, Kirchmair M, Jenewein I, Ledochowski M, Dierich MP.

Int J Med Microbiol. 2002 Mar;291(8):655-7.

PMID:
12008920
10.

Antifungal properties of 5-hydroxytryptamine (serotonin) against Candida species in vitro.

Lass-Flörl C, Fuchs D, Ledochowski M, Speth C, Dierich MP, Würzner R.

J Med Microbiol. 2003 Feb;52(Pt 2):169-71.

PMID:
12543924
11.

In vitro susceptibility of Aspergillus spp. clinical isolates to albendazole.

Berthet N, Faure O, Bakri A, Ambroise-Thomas P, Grillot R, Brugère JF.

J Antimicrob Chemother. 2003 Jun;51(6):1419-22. Epub 2003 Apr 25.

PMID:
12716778
12.

A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.

Krishnan S, Manavathu EK, Chandrasekar PH.

J Antimicrob Chemother. 2005 Jun;55(6):914-20. Epub 2005 Apr 11.

PMID:
15824093
13.

In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil.

Bedin Denardi L, Hoch Dalla-Lana B, Pantella Kunz de Jesus F, Bittencourt Severo C, Morais Santurio J, Zanette RA, Hartz Alves S.

Braz J Infect Dis. 2018 Jan - Feb;22(1):30-36. doi: 10.1016/j.bjid.2017.10.005. Epub 2017 Nov 22.

14.

In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.

Mallié M, Bastide JM, Blancard A, Bonnin A, Bretagne S, Cambon M, Chandenier J, Chauveau V, Couprie B, Datry A, Feuilhade M, Grillot R, Guiguen C, Lavarde V, Letscher V, Linas MD, Michel A, Morin O, Paugam A, Piens MA, Raberin H, Tissot E, Toubas D, Wade A.

Int J Antimicrob Agents. 2005 Apr;25(4):321-8.

PMID:
15784312
15.

2-hydroxyisocaproic acid is fungicidal for Candida and Aspergillus species.

Sakko M, Moore C, Novak-Frazer L, Rautemaa V, Sorsa T, Hietala P, Järvinen A, Bowyer P, Tjäderhane L, Rautemaa R.

Mycoses. 2014 Apr;57(4):214-21. doi: 10.1111/myc.12145. Epub 2013 Oct 11.

PMID:
24125484
16.

Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.

Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM, Yan JJ, Yu KW, Wu JJ, Ko WC, Yang YC, Liu YC, Teng LJ, Liu CY, Luh KT.

Antimicrob Agents Chemother. 2005 Feb;49(2):512-7.

17.

In vitro antifungal activity of 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate, a dihydropyrrole derivative.

Dabur R, Chhillar AK, Yadav V, Kamal PK, Gupta J, Sharma GL.

J Med Microbiol. 2005 Jun;54(Pt 6):549-52.

PMID:
15888463
18.

Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline.

Lass-Flörl C, Dierich MP, Fuchs D, Semenitz E, Ledochowski M.

Clin Infect Dis. 2001 Dec 15;33(12):E135-6. Epub 2001 Nov 7.

PMID:
11700578
19.

Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus.

Rodrigues AG, Araujo R, Pina-Vaz C.

Int J Antimicrob Agents. 2006 Apr;27(4):339-43. Epub 2006 Mar 9.

PMID:
16527460
20.

In vitro anti-Candida activity of selective serotonin reuptake inhibitors against fluconazole-resistant strains and their activity against biofilm-forming isolates.

Costa Silva RA, da Silva CR, de Andrade Neto JB, da Silva AR, Campos RS, Sampaio LS, do Nascimento FBSA, da Silva Gaspar B, da Cruz Fonseca SG, Josino MAA, Grangeiro TB, Gaspar DM, de Lucena DF, de Moraes MO, Cavalcanti BC, Nobre Júnior HV.

Microb Pathog. 2017 Jun;107:341-348. doi: 10.1016/j.micpath.2017.04.008. Epub 2017 Apr 12.

Supplemental Content

Support Center